Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Overview
Explore Shuttle Pharmaceuticals Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Key Financials
Key Financials
Market Cap
2.5M
P/E Ratio
-0.07
EPS (TTM)
$-21.54
ROE
-4.08%
SHPH Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Shuttle Pharmaceuticals Holdings, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SHPH on the NASDAQ shows an RSI of 56.95, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Shuttle Pharmaceuticals Holdings, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.07 and a market capitalization of 2.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SHPH on the NASDAQ.